X0306 4 2023-02-06 0 0001805387 Cerevel Therapeutics Holdings, Inc. CERE 0001830371 Bodenrader Mark C/O CEREVEL THERAPEUTICS HOLDINGS, INC. 222 JACOBS STREET, SUITE 200 CAMBRIDGE MA 02141 0 1 0 0 See Remarks Stock Option (Right to Buy) 34.41 2023-02-06 4 A 0 20012 0.00 A 2033-02-06 Common Stock 20012 20012 D Restricted Stock Units 2023-02-06 4 A 0 5085 0.00 A Common Stock 5085 5085 D 25% of this option shall vest and become exercisable on February 6, 2024, with the remainder vesting in thirty-six (36) monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date. The shares reported in this transaction represent Restricted Stock Units ("RSUs") granted under the Cerevel Therapeutics Holdings, Inc. 2020 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's common stock. The RSUs vest in four equal annual installments on each of February 6, 2024, February 6, 2025, February 6, 2026 and February 6, 2027, subject to the Reporting Person's continued service on each such vesting date. Exhibit 24 - Power of Attorney. Officer title: Interim Chief Financial Officer, Senior Vice President, Finance and Chief Accounting Officer /s/ Mark Bodenrader 2023-02-08